I have just had a look at the 3/4 results for OMi , and it says...

I have just had a look at the 3/4 results for OMi , and it says omi only has 800k left in cash. Considering they spent 750k last quater, then they are sitting in a very unsafe position. Uni are the same they had 11.5mill last quarter and now they are down to 9 million, 2 million spent in the last 1/4. This is why i think ems is the best of the bunch. only spent 230k last quater( alot spent on patents) but are expected to turn a profit this fianacial year. They had 1.7 million in revenue compared to uni at 0 and omi at i think 30k. EMS is a sound bussiness right now, which is a solid base for there run into international markets(emsplc being set up right now to expand into the usa and europe (www.emsplc.co.uk) Terumo still interested in the clip-on even though OMI recently signed contracts with them for the south pacific(very small area). I think OMI has a great product but ems will provide a very good product and a closer price to the sandard syringes currently being used around the world. July is when fund brokers will get involved.

cheers

Always do your own research.